Cat Reville is an expert Associate Director for oncology and digital health topics, and the biopharma R&D capability lead, for Boston Consulting Group's Center for Oncology Insights. She is a core member of BCG's Health Care practice. Cat joined the firm in April 2022, bringing ten years of experience working along the health care value chain.

Prior to joining BCG, Cat was part of the corporate strategy team at McKesson, advancing their oncology business enterprise. She has experience in management consulting at Deloitte Consulting where she innovated digital R&D and clinical ops models for top biopharma clients. Additionally, Cat has industry experience in global commercialization of molecular diagnostic products.


  • MS, biotechnology, University of Wisconsin, Madison 
  • BS, biology/neuroscience, Denison University